AngioDynamics Earnings Estimate

ANGO Stock  USD 12.46  0.05  0.40%   
The next projected EPS of AngioDynamics is estimated to be -0.13 with future projections ranging from a low of -0.14 to a high of -0.11. AngioDynamics' most recent 12-month trailing earnings per share (EPS TTM) is at -5.59. Please be aware that the consensus of earnings estimates for AngioDynamics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
AngioDynamics is projected to generate -0.13 in earnings per share on the 28th of February 2025. AngioDynamics earnings estimates show analyst consensus about projected AngioDynamics EPS (Earning Per Share). It derives the highest and the lowest estimates based on AngioDynamics' historical volatility. Many public companies, such as AngioDynamics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

AngioDynamics Revenue Breakdown by Earning Segment

By analyzing AngioDynamics' earnings estimates, investors can diagnose different trends across AngioDynamics' analyst sentiment over time as well as compare current estimates against different timeframes. As of the 31st of January 2025, Gross Profit Margin is likely to grow to 0.59, while Gross Profit is likely to drop about 131.3 M.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

AngioDynamics Earnings Estimation Breakdown

The calculation of AngioDynamics' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of AngioDynamics is estimated to be -0.13 with the future projection ranging from a low of -0.14 to a high of -0.11. Please be aware that this consensus of annual earnings estimates for AngioDynamics is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.04
-0.14
Lowest
Expected EPS
-0.13
-0.11
Highest

AngioDynamics Earnings Projection Consensus

Suppose the current estimates of AngioDynamics' value are higher than the current market price of the AngioDynamics stock. In this case, investors may conclude that AngioDynamics is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and AngioDynamics' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 28th of February 2025Current EPS (TTM)
321.11%
-0.04
-0.13
-5.59

AngioDynamics Earnings per Share Projection vs Actual

Actual Earning per Share of AngioDynamics refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering AngioDynamics predict the company's earnings will be in the future. The higher the earnings per share of AngioDynamics, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

AngioDynamics Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as AngioDynamics, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of AngioDynamics should always be considered in relation to other companies to make a more educated investment decision.

AngioDynamics Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact AngioDynamics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-01-03
2024-11-30-0.11-0.040.0763 
2024-10-03
2024-08-31-0.15-0.110.0426 
2024-07-16
2024-05-31-0.17-0.060.1164 
2024-04-04
2024-02-29-0.14-0.16-0.0214 
2024-01-05
2023-11-30-0.07-0.050.0228 
2023-10-04
2023-08-31-0.13-0.120.01
2023-07-12
2023-05-310.020.020.0
2023-03-30
2023-02-28-0.01-0.03-0.02200 
2023-01-05
2022-11-30-0.010.010.02200 
2022-10-06
2022-08-31-0.02-0.06-0.04200 
2022-07-12
2022-05-310.010.010.0
2022-04-07
2022-02-28-0.010.030.04400 
2022-01-06
2021-11-300.01-0.02-0.03300 
2021-09-30
2021-08-31-0.04-0.020.0250 
2021-07-13
2021-05-31-0.0033-0.5053-0.50215212 
2021-03-30
2021-02-28-0.020.020.04200 
2021-01-07
2020-11-30-0.020.010.03150 
2020-09-29
2020-08-31-0.070.020.09128 
2020-07-16
2020-05-31-0.06-0.060.0
2020-04-07
2020-02-29-0.030.010.04133 
2020-01-07
2019-11-300.020.060.04200 
2019-10-03
2019-08-310.040.080.04100 
2019-07-10
2019-05-310.260.25-0.01
2019-04-02
2019-02-280.220.19-0.0313 
2019-01-04
2018-11-300.210.220.01
2018-09-27
2018-08-310.180.16-0.0211 
2018-07-11
2018-05-310.210.2-0.01
2018-03-29
2018-02-280.190.250.0631 
2018-01-04
2017-11-300.160.160.0
2017-09-28
2017-08-310.160.12-0.0425 
2017-07-18
2017-05-310.160.190.0318 
2017-03-30
2017-02-280.150.190.0426 
2017-01-06
2016-11-300.160.190.0318 
2016-10-05
2016-08-310.130.170.0430 
2016-07-13
2016-05-310.160.190.0318 
2016-04-07
2016-02-290.140.150.01
2016-01-07
2015-11-300.140.140.0
2015-10-08
2015-08-310.110.110.0
2015-07-16
2015-05-310.140.140.0
2015-04-09
2015-02-280.160.12-0.0425 
2015-01-08
2014-11-300.150.170.0213 
2014-10-09
2014-08-310.110.160.0545 
2014-07-23
2014-05-310.120.11-0.01
2014-04-09
2014-02-280.090.08-0.0111 
2014-01-09
2013-11-300.070.06-0.0114 
2013-10-10
2013-08-310.030.040.0133 
2013-07-11
2013-05-310.060.070.0116 
2013-04-08
2013-02-280.050.080.0360 
2013-01-03
2012-11-300.090.10.0111 
2012-10-08
2012-08-310.090.10.0111 
2012-07-12
2012-05-310.090.110.0222 
2012-04-04
2012-02-290.080.090.0112 
2012-01-05
2011-11-300.120.130.01
2011-10-06
2011-08-310.080.080.0
2011-07-14
2011-05-310.10.110.0110 
2011-04-05
2011-02-280.120.150.0325 
2011-01-04
2010-11-300.120.150.0325 
2010-10-07
2010-08-310.080.080.0
2010-07-15
2010-05-310.130.150.0215 
2010-03-31
2010-02-280.120.130.01
2010-01-05
2009-11-300.110.130.0218 
2009-10-06
2009-08-310.080.090.0112 
2009-07-16
2009-05-310.150.14-0.01
2009-04-02
2009-02-280.110.150.0436 
2009-01-06
2008-11-300.120.120.0
2008-10-02
2008-08-310.090.090.0
2008-07-24
2008-05-310.170.190.0211 
2008-04-02
2008-02-290.120.120.0
2008-01-03
2007-11-300.130.130.0
2007-10-01
2007-08-310.10.10.0
2007-07-24
2007-05-310.120.120.0
2007-03-27
2007-02-280.160.12-0.0425 
2007-01-03
2006-11-300.130.150.0215 
2006-09-25
2006-08-310.10.120.0220 
2006-08-10
2006-05-310.20.19-0.01
2006-03-21
2006-02-280.140.140.0
2005-12-19
2005-11-300.120.130.01
2005-09-27
2005-08-310.090.10.0111 
2005-07-22
2005-05-310.110.130.0218 
2005-03-29
2005-02-280.080.090.0112 
2004-12-20
2004-11-300.050.090.0480 
2004-10-07
2004-08-310.040.060.0250 
2004-07-29
2004-05-310.080.150.0787 

About AngioDynamics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of AngioDynamics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current AngioDynamics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as AngioDynamics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-355.7 M-337.9 M
Retained Earnings Total Equity-189.8 M-180.3 M
Earnings Yield(0.84)(0.79)
Price Earnings Ratio(1.58)(1.50)
Price Earnings To Growth Ratio(0.01)(0.01)

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving together with AngioDynamics Stock

  0.76AHG Akso Health GroupPairCorr
  0.61CAH Cardinal HealthPairCorr

Moving against AngioDynamics Stock

  0.88HCAT Health CatalystPairCorr
  0.68XAIR Beyond AirPairCorr
  0.66NRC National Research CorpPairCorr
  0.61VMD Viemed HealthcarePairCorr
  0.56TFX Teleflex IncorporatedPairCorr
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.59)
Revenue Per Share
7.249
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.06)
Return On Equity
(0.78)
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.